Adaptive Biotechnologies (ADPT) Interest & Investment Income (2018 - 2026)

Adaptive Biotechnologies has disclosed Interest & Investment Income across 9 years of filings, most recently posting $2.1 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.1 million, down 22.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.8 million (down 31.91% YoY), and the FY2025 annual result was $9.4 million, down 35.02% from the prior year.
• Interest & Investment Income came in at $2.1 million for Q1 2026 at Adaptive Biotechnologies, down from $2.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.6 million in Q4 2023 to a low of $271000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $2.7 million (2025), against an average of $2.7 million.
• Across the five-year window, Interest & Investment Income tumbled 57.52% in 2022 and soared 1015.87% in 2023, its largest moves.
• Adaptive Biotechnologies' Interest & Investment Income stood at $2.6 million in 2022, then surged by 77.29% to $4.6 million in 2023, then slumped by 33.41% to $3.1 million in 2024, then tumbled by 30.08% to $2.1 million in 2025, then declined by 3.17% to $2.1 million in 2026.
• The last three Interest & Investment Income figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.